SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zydus Lifesciences informs about transcript of AGM

24 Sep 2025 Evaluate
Zydus Lifesciences has informed that it enclosed the transcript of the 30th Annual General Meeting of the Company held on Tuesday, August 12, 2025. The same is also posted on the website of the Company at www.zyduslife.com.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

930.95 7.85 (0.85%)
15-Apr-2026 10:18 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1670.40
Dr. Reddys Lab 1213.60
Cipla 1225.95
Zydus Lifesciences 930.95
Lupin 2336.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×